Advertisement
Screener

REVVITY, INC (RVTY) Overview

REVVITY, INC (RVTY) Overview

  • 6 Apr 2026: Period ending 5 Jul 2026; Estimate (m); Actual 0.47; Beat / miss (m).
  • 29 Dec 2025: Period ending 5 Apr 2026; Estimate (m); Actual 0.36; Beat / miss (m).
  • 30 Jun 2025: Period ending 28 Sept 2025; Estimate (m); Actual 0.40; Beat / miss (m).
  • 31 Mar 2025: Period ending 29 Jun 2025; Estimate (m); Actual 0.46; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$78.15$90.52$104.84$121.44$140.66$162.922025-11-062026-11-06$77.98$95.16$116.14$141.74$172.98$211.112021-11-082026-11-06$47.45$64.16$86.76$117.31$158.63$214.492016-11-072026-11-06$10.45$19.51$36.44$68.05$127.08$237.312006-11-062026-11-06$0.43$1.67$6.49$25.27$98.44$383.461973-02-212026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$155.16
Previous close
$152.77
Change
$2.39
Change (%)
1.56%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

RVTY
+58.23%
S&P 500
(m)

1 year

RVTY
+81.95%
S&P 500
(m)

3 years

RVTY
+39.13%
S&P 500
(m)

5 years

RVTY
-11.67%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

5 Jul 2026 ○ Estimate (m) ● Actual 0.47

0.270.360.460.550.6530 Mar 2025: estimate (m); actual 0.3530 Mar 2025(m)29 Jun 2025: estimate (m); actual 0.4629 Jun 2025(m)28 Sept 2025: estimate (m); actual 0.4028 Sept 2025(m)5 Apr 2026: estimate (m); actual 0.365 Apr 2026(m)5 Jul 2026: estimate (m); actual 0.475 Jul 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
6 Apr 20265 Jul 2026(m)0.47(m)(m)
29 Dec 20255 Apr 2026(m)0.36(m)(m)
30 Jun 202528 Sept 2025(m)0.40(m)(m)
31 Mar 202529 Jun 2025(m)0.46(m)(m)
30 Dec 202430 Mar 2025(m)0.35(m)(m)

28 Dec 2025 ○ Estimate (m) ● Actual 2.07

1.993.565.136.698.262 Jan 2022: estimate (m); actual 8.082 Jan 2022(m)1 Jan 2023: estimate (m); actual 4.501 Jan 2023(m)31 Dec 2023: estimate (m); actual 5.5531 Dec 2023(m)29 Dec 2024: estimate (m); actual 2.2029 Dec 2024(m)28 Dec 2025: estimate (m); actual 2.0728 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
30 Dec 202428 Dec 2025(m)2.07(m)(m)
1 Jan 202429 Dec 2024(m)2.20(m)(m)
2 Jan 202331 Dec 2023(m)5.55(m)(m)
3 Jan 20221 Jan 2023(m)4.50(m)(m)
4 Jan 20212 Jan 2022(m)8.08(m)(m)

Revenue vs. Earnings

USD

5 Jul 2026 ■ Revenue 729.69M ■ Earnings 51.82M — Profit margin 7.10%

-92.65M4.7%226.47M7.7%545.59M10.7%864.70M13.7%28 Sept 2025: revenue 698.95M; earnings 46.65M; profit margin 6.67%28 Sept 202528 Dec 2025: revenue 772.06M*; earnings 98.36M*; profit margin 12.74%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-09-29 to 2025-12-28; USD.28 Dec 20255 Apr 2026: revenue 711.12M; earnings 40.72M; profit margin 5.73%5 Apr 20265 Jul 2026: revenue 729.69M; earnings 51.82M; profit margin 7.10%5 Jul 2026

28 Dec 2025 ■ Revenue 2.86B ■ Earnings 0.24B — Profit margin 8.45%

-0.40B7.4%0.97B13.7%2.34B19.9%3.71B26.2%1 Jan 2023: revenue 3.31B; earnings 0.57B; profit margin 17.19%1 Jan 202331 Dec 2023: revenue 2.75B; earnings 0.69B; profit margin 25.20%31 Dec 202329 Dec 2024: revenue 2.76B; earnings 0.27B; profit margin 9.81%29 Dec 202428 Dec 2025: revenue 2.86B; earnings 0.24B; profit margin 8.45%28 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$155.16(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$155.16High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning RVTY

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Index membership
(m)
Employees
11.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.19M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
6.60%*
Total return · month
18.61%*
Total return · quarter
37.46%*
Total return · half year
82.35%*
Total return · year to date
58.23%*
Total return · 1 year
81.95%*
Total return · 3 years
39.13%*
Total return · 5 years
-11.67%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

REVVITY, INC Overview

View more →

(m)

(m)

SEC CIK
31791
Industry (SIC)
3826 Laboratory Analytical Instruments
Country of operation
United States
Business address
77 4TH AVENUE, WALTHAM, Massachusetts, 02451, United States
Fiscal year end
1229
Phone
781-663-6900

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16